AAAAAA

   
Results: 1-10 |
Results: 10

Authors: PAUL C TIDEFELT U GRUBER A LILIEMARK E SUNDMANENGBERG B JULIUSSON G STENKE L ELMHORNROSENBORG A MOLLGARD L LEHMANN S COVELLI A MALKHANDI J GUSTAVSSON B LILIEMARK J
Citation: C. Paul et al., THE P-GLYCOPROTEIN INHIBITOR (PGP) PSC-833 INCREASES THE INTRACELLULAR CONCENTRATIONS OF DAUNORUBICIN (DNR) IN-VIVO IN PATIENTS WITH PGP POSITIVE AML, Blood, 90(10), 1997, pp. 805-805

Authors: LILIEMARK E HERNGREN L PETTERSSON B PETERSON C LILIEMARK J
Citation: E. Liliemark et al., ULTRAFILTRATION AND SUBSEQUENT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHYFOR IN-VIVO DETERMINATIONS OF THE PROTEIN-BINDING OF ETOPOSIDE, Cancer letters, 106(1), 1996, pp. 91-96

Authors: LILIEMARK E SODERHALL S SIRZEA F GRUBER A OSBY E BJORKHOLM M ZHOU R PETERSON C LILIEMARK J
Citation: E. Liliemark et al., HIGHER IN-VIVO PROTEIN-BINDING OF ETOPOSIDE IN CHILDREN COMPARED WITHADULT CANCER-PATIENTS, Cancer letters, 106(1), 1996, pp. 97-100

Authors: WALLES SAS ZHOU R LILIEMARK E
Citation: Sas. Walles et al., DNA-DAMAGE INDUCED BY ETOPOSIDE - A COMPARISON OF 2 DIFFERENT METHODSFOR DETERMINATION OF STRAND BREAKS IN DNA, Cancer letters, 105(2), 1996, pp. 153-159

Authors: LILIEMARK E LILIEMARK J ZHOU R GRUBER A
Citation: E. Liliemark et al., PROLONGED RETENTION OF ETOPOSIDE IN MDR1 EXPRESSING CELLS IN-VIVO BY TREATMENT WITH CYCLOSPORINE-A, Blood, 88(10), 1996, pp. 3321-3321

Authors: LILIEMARK E PETTERSSON B PETERSON C LILIEMARK J
Citation: E. Liliemark et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION FOR MONITORING OF ETOPOSIDE AND ITS CIS-ISOMER IN PLASMA AND LEUKEMIC-CELLS, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 311-317

Authors: LILIEMARK E SJOSTROM B LILIEMARK J PETERSON C KALLBERG N LARSSON BS
Citation: E. Liliemark et al., TARGETING OF TENIPOSIDE TO THE MONONUCLEAR PHAGOCYTIC SYSTEM (MPS) BYINCORPORATION IN LIPOSOMES AND SUBMICRON LIPID PARTICLES - AN AUTORADIOGRAPHIC STUDY IN MICE, Leukemia & lymphoma, 18(1-2), 1995, pp. 113-118

Authors: GRUBER A LILIEMARK E TIDEFELT U PAUL C BJORKHOLM M PETERSON C LILIEMARK J
Citation: A. Gruber et al., PHARMACOKINETICS OF MITOXANTRONE, ETOPOSIDE AND CYTOSINE-ARABINOSIDE IN LEUKEMIC-CELLS DURING TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP TO TREATMENT OUTCOME AND BONE-MARROW TOXICITY, Leukemia research, 19(10), 1995, pp. 757-761

Authors: LILIEMARK E LILIEMARK J KALLBERG N BJORKHOLM M SJOSTROM B PETERSON C
Citation: E. Liliemark et al., STUDIES OF THE ORGAN DISTRIBUTION IN MICE OF TENIPOSIDE LIPOSOMES DESIGNED FOR TREATMENT OF DISEASES IN THE MONONUCLEAR PHAGOCYTIC SYSTEM, Pediatric research, 38(1), 1995, pp. 7-10

Authors: LILIEMARK E ZHOU R LILIEMARK J GRUBER A WALLES S
Citation: E. Liliemark et al., DNA STRAND BREAKS INDUCED BY ETOPOSIDE AND THEIR RELATION TO CELLULARETOPOSIDE CONCENTRATIONS IN CEM-CELLS AND IN CELLS FROM PATIENTS WITHAML AND CLL, Blood, 86(10), 1995, pp. 3058-3058
Risultati: 1-10 |